| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.6 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |